Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization...

Area of Science:

• Cardiology
• Electrophysiology
• Heart Failure Management

Background:

• The necessity of prophylactic implantable cardioverter-defibrillator (ICD) implantation in patients with systolic heart failure (HF) undergoing cardiac resynchronization therapy (CRT) is debated.
• Identifying patients at low risk for sustained ventricular arrhythmias is crucial for optimizing treatment strategies.

Purpose of the Study:

• To identify patients with heart failure undergoing CRT who are at low risk for sustained ventricular arrhythmias.
• To evaluate the effectiveness of prophylactic ICD implantation in this patient population.

Main Methods:

• A cohort of 169 consecutive patients with HF referred for CRT and prophylactic ICD implantation were assessed.
• Baseline clinical and echocardiographic data were collected, and patients were followed up for appropriate ICD therapy.
• Multivariate analysis was used to identify independent predictors of appropriate ICD therapy.

Main Results:

• During a mean follow-up of 654 days, 21% of patients received appropriate ICD therapy for sustained ventricular arrhythmias.
• Independent predictors of appropriate ICD therapy included a history of non-sustained ventricular tachycardia, left ventricular ejection fraction <20%, and digitalis therapy.
• Patients with zero or one risk factor had a significantly lower incidence of appropriate ICD therapy compared to those with two or three risk factors.

Conclusions:

• Prophylactic ICD implantation appears less effective in CRT patients without non-sustained ventricular tachycardia, digitalis therapy, and severely reduced left ventricular systolic function.
• Risk stratification using these factors can help personalize ICD decision-making in CRT candidates.
• Further research may refine criteria for ICD necessity in heart failure patients undergoing CRT.